High Court Clears Path for Puberty Blockers Trial in UK
Puberty blockers trial can start recruiting children
The High Court has rejected a legal challenge, allowing the Pathways trial by King's College London to begin recruiting children aged 11 to 16. This study aims to assess the benefits and risks of puberty blockers following a government ban on routine use. While researchers emphasize strict safety protocols and thorough assessments, campaigners remain concerned about the ethical implications and long-term effects on young people.
The medical profession and morality do not always walk hand-in-hand. If they did, this trial would be out of the question.